Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Renin-Angiotensin-System Quantification in Patients Treated With Aliskiren or Candesartan (RASQAL)

NCT01827202 is registered in ClinicalTrials.gov with Medical University of Vienna as lead sponsor.

NCT NCT01827202
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01827202 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Renin-Angiotensin-System Quantification in Patients Treated With Aliskiren or Candesartan (RASQAL)
Lead sponsor
Medical University of Vienna
Phase
Phase 4
Overall status
Completed
Start date
December 31, 2012
Completion date
February 29, 2016
Enrollment
24 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

chronic kidney disease, hypertension, proteinuria